Bausch Health Companies Inc. announced that it will expand its Board of Directors to add two designees to the Board from Carl C. Icahn and affiliated entities. The Company has entered into a director nomination and appointment agreement with the Icahn Group, pursuant to which Brett Icahn and Steven Miller will be appointed to the Board as new independent directors, effective in mid-March 2021, with each to serve a term expiring at the Company's 2021 Annual Meeting. The Company has also agreed to include Messrs. B. Icahn and Miller on its slate of nominees for election at the Company's 2021 Annual Meeting, which will be held on April 27, 2021. Concurrently with their appointments to the Board, Messrs. B. Icahn and Miller will be appointed to two Board committees, the Finance and Transactions Committee and the committee assisting with evaluating strategic alternatives, including the potential spin of the Company's eye health business. With new appointments the Board will consist of thirteen (13) highly qualified directors, twelve (12) of whom are independent.